Arcutis Biotherapeutics CEO Todd Watanabe sells $74,892 in stock

Form 144 RADCOM LTD For: 6 May

Investing.com · News 14m ago

H&R Block Q3 FY26 slides: AI strategy drives earnings beat, guidance raised

Investing.com · News 15m ago

Blue Bird Q2 FY2026 slides: Micro Bird buy lifts guidance to $245M

Investing.com · News 15m ago

Evertec Q1 2026 slides: revenue tops estimates, Dimensa deal expands reach

Investing.com · News 15m ago

Anxious Australian Retirees Ramp Up Pension Fund Withdrawals

Bloomberg · Markets 15m ago

Oil Steadies as the US and Iran Weigh Fresh Proposal to End War

Bloomberg · Markets 18m ago

Apollo Seeks an Edge With Credit Fund Transparency Push

Dow Jones · Markets 22m ago

Autoliv declares quarterly dividend of 87 cents per share

Investing.com · News 24m ago

Blue Owl private credit fund cuts dividend as borrowing costs rise

Investing.com · News 25m ago

Trump brothers-backed American Bitcoin narrows loss on stronger mining revenue

Investing.com · News 25m ago